Veri Medtech Holdings operates a telehealth platform, primarily through its subsidiary Veriheal, that connects patients with licensed physicians to obtain and renew medical marijuana card certifications. Patients use the platform to schedule telemedicine consultations, consult with contracted physicians, and receive state-approved medical cannabis certifications and application processing across more than 40 U.S. states and the District of Columbia. Veri Medtech charges patients a flat service fee per consultation, recognizing revenue upon completion of the medical evaluation and certification issuance, with annual card expiration requirements providing a recurring customer base. The company acquires patients directly through digital marketing channels and its dedicated lead-generation website. Its primary costs include contracted physician consultation fees, payment processing fees, and digital advertising expenses. Beyond its core cannabis certification business, Veri Medtech is expanding into general wellness telehealth through DosePop, a direct-to-consumer platform offering prescription treatments for weight loss, dermatology, and mental health, with plans to cross-sell these services to its existing patient base alongside geographic expansion.